{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:38:58Z","timestamp":1790192338464,"version":"4.1.0"},"reference-count":140,"publisher":"Akademiai Kiado Zrt.","issue":"1","funder":[{"name":"Development Program with a Business Plan for the Laboratory Complex of Sofia Tech Park","award":["BG16RFPR002-1.014-0014-C01"],"award-info":[{"award-number":["BG16RFPR002-1.014-0014-C01"]}]}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMICR"],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The present study aimed to investigate the resistome of four trimethoprim\u2013sulfamethoxazole (SXT)-resistant\n                    <jats:italic>Stenotrophomonas maltophilia<\/jats:italic>\n                    complex (Smc) isolates from Bulgarian hematopoietic stem cell transplantation (HSCT) recipients and to subject them to phylogenomic analysis involving all\n                    <jats:italic>sul1<\/jats:italic>\n                    -positive strains of the identified species with available genomes worldwide. Preliminary identification by MALDI-TOF mass spectrometry determined all four isolates as\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    . The sources of isolation were stools (SM175, SM176, and SM179) and urine (SM178). SM176 and SM178 also showed high-level levofloxacin resistance. All isolates demonstrated\n                    <jats:italic>in vitro<\/jats:italic>\n                    susceptibility to minocycline and cefiderocol. Whole-genome sequencing (WGS) assigned SM175, SM176, and SM178 as\n                    <jats:italic>Stenotrophomonas forensis<\/jats:italic>\n                    . Two types of class 1 integrons were detected in the four isolates, namely SM175 and SM179 carried empty integrons, whereas SM176 and SM178 carried a gene cassette (3,748 bp in length) consisting of\n                    <jats:italic>aac6\u2032-Ib<\/jats:italic>\n                    \u2013\n                    <jats:italic>cmlB<\/jats:italic>\n                    \u2013\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA-9<\/jats:sub>\n                    . Alignment against public databases revealed that this cassette has not been found in\n                    <jats:italic>Stenotrophomonas<\/jats:italic>\n                    species so far, but it was present in\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    and\n                    <jats:italic>Enterobacterales<\/jats:italic>\n                    . Phylogenomic analysis of our assembled sequences, together with all 26\n                    <jats:italic>sul1<\/jats:italic>\n                    -positive\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    and\n                    <jats:italic>S. forensis<\/jats:italic>\n                    genomes, indicated that\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    SM179 was not part of any\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    cluster. SM175, SM176, and SM178 were closely related (differences of 35\u2013101 SNPs). To the best of our knowledge, this is the first report of SXT-resistant Smc isolates from post-HSCT patients with hematological malignancies in Bulgaria, which presents WGS-based resistome and phylogenomic analyses. We also report on the first\n                    <jats:italic>sul1<\/jats:italic>\n                    -containing\n                    <jats:italic>S. forensis<\/jats:italic>\n                    clinical isolates. Our findings reveal high global heterogeneity of\n                    <jats:italic>sul1<\/jats:italic>\n                    -positive\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1556\/030.2026.02794","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:04:54Z","timestamp":1768554294000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":2,"title":["Resistome and phylogenomic analysis of trimethoprim\u2013sulfamethoxazole-resistant Stenotrophomonas maltophilia complex isolates obtained from Bulgarian hematopoietic stem cell transplant recipients"],"prefix":"10.1556","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-1849","authenticated-orcid":true,"given":"Tanya","family":"Strateva","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology \u201cCorr. Mem. Prof. Ivan Mitov, MD, DMSc\u201d, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3666-3802","authenticated-orcid":true,"given":"Denis","family":"Niyazi","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, University Hospital \u201cSt. Marina\u201d, Varna, Bulgaria"},{"name":"Department of Microbiology and Virology, Faculty of Medicine, Medical University of Varna, Varna, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-4532","authenticated-orcid":true,"given":"Temenuga","family":"Stoeva","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, University Hospital \u201cSt. Marina\u201d, Varna, Bulgaria"},{"name":"Department of Microbiology and Virology, Faculty of Medicine, Medical University of Varna, Varna, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-9511","authenticated-orcid":true,"given":"Slavil","family":"Peykov","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology \u201cCorr. Mem. Prof. Ivan Mitov, MD, DMSc\u201d, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria"},{"name":"Department of Genetics, Faculty of Biology, Sofia University \u201cSt. Kliment Ohridski\u201d, Sofia, Bulgaria"},{"name":"BioInfoTech Laboratory, Sofia Tech Park, Research & Development & Innovation Consortium, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"B1","series-title":"Clin Microbiol Rev","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00030-19","article-title":"Advances in the microbiology of Stenotrophomonas maltophilia","volume":"34","author":"Brooke JS","year":"2021","unstructured":"Brooke JS. Advances in the microbiology of Stenotrophomonas maltophilia. Clin Microbiol Rev 2021; 34: e00030-19. 10.1128\/CMR.00030-19https:\/\/doi.org\/10.1128\/CMR.00030-19"},{"key":"B2","series-title":"Front Cell Infect Microbiol","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1325379","article-title":"Stenotrophomonas maltophilia complex: insights into evolutionary relationships, global distribution and pathogenicity","volume":"13","author":"Li K","year":"2024","unstructured":"Li K, Yu K, Huang Z, Liu X, Mei L, Ren X, et al. Stenotrophomonas maltophilia complex: insights into evolutionary relationships, global distribution and pathogenicity. Front Cell Infect Microbiol 2024; 13: 1325379. 10.3389\/fcimb.2023.1325379https:\/\/doi.org\/10.3389\/fcimb.2023.1325379"},{"key":"B3","series-title":"Biofilm","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2025.100253","article-title":"Role of SMF-1 and Cbl pili in Stenotrophomonas maltophilia biofilm formation","volume":"9","author":"Bhaumik R","year":"2025","unstructured":"Bhaumik R, Beard A, Harrigan O, Ramos-Hegazy L, Mattoo S, Anderson GG. Role of SMF-1 and Cbl pili in Stenotrophomonas maltophilia biofilm formation. Biofilm 2025; 9: 100253. 10.1016\/j.bioflm.2025.100253https:\/\/doi.org\/10.1016\/j.bioflm.2025.100253"},{"key":"B4","series-title":"Acta Microbiol Immunol Hung","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1556\/030.2023.01920","article-title":"Analysis of biofilm formation in nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria: an 11-year study (2011\u20132022)","volume":"70","author":"Strateva T","year":"2023","unstructured":"Strateva T, Trifonova A, Sirakov I, Borisova D, Stancheva M, Keuleyan E, et al. Analysis of biofilm formation in nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria: an 11-year study (2011\u20132022). Acta Microbiol Immunol Hung 2023; 70: 11\u201321. 10.1556\/030.2023.01920https:\/\/doi.org\/10.1556\/030.2023.01920"},{"key":"B5","series-title":"CMI Commun","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmicom.2025.105082","article-title":"Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review","volume":"2","author":"Turnidge J","year":"2025","unstructured":"Turnidge J, Gatermann S, Kahlmeter G, Cant\u00f3n R, Wootton M, Giske CG. Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review. CMI Commun 2025; 2: 105082. 10.1016\/j.cmicom.2025.105082https:\/\/doi.org\/10.1016\/j.cmicom.2025.105082"},{"key":"B6","series-title":"Acta Microbiol Immunol Hung","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1556\/030.2025.02578","article-title":"Efflux pump systems as key contributors to multidrug resistance in Stenotrophomonas maltophilia: physiological roles and gene regulation","volume":"72","author":"Vattanaviboon P","year":"2025","unstructured":"Vattanaviboon P, Dulyayangkul P, Mongkolsuk S, Charoenlap N. Efflux pump systems as key contributors to multidrug resistance in Stenotrophomonas maltophilia: physiological roles and gene regulation. Acta Microbiol Immunol Hung 2025; 72: 81\u201392. 10.1556\/030.2025.02578https:\/\/doi.org\/10.1556\/030.2025.02578"},{"key":"B7","series-title":"Antibiotics","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/antibiotics13070577","article-title":"Stenotrophomonas maltophilia: the landscape in critically ill patients and optimising management approaches","volume":"13","author":"Carbonell N","year":"2024","unstructured":"Carbonell N, Oltra MR, Clari M\u00c1. Stenotrophomonas maltophilia: the landscape in critically ill patients and optimising management approaches. Antibiotics 2024; 13: 577. 10.3390\/antibiotics13070577https:\/\/doi.org\/10.3390\/antibiotics13070577"},{"key":"B8","series-title":"Chest","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1378\/chest.15-0676","article-title":"Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis","volume":"149","author":"Salsgiver EL","year":"2016","unstructured":"Salsgiver EL, Fink AK, Knapp EA, LiPuma JJ, Olivier KN, Marshall BC, et al. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis. Chest 2016; 149: 390\u2013400. 10.1378\/chest.15-0676https:\/\/doi.org\/10.1378\/chest.15-0676"},{"key":"B9","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1093\/cid\/ciu612","article-title":"Antibiotic-resistant Gram-negative bacterial infections in patients with cancer","volume":"59","author":"Perez F","year":"2014","unstructured":"Perez F, Adachi J, Bonomo RA. Antibiotic-resistant Gram-negative bacterial infections in patients with cancer. Clin Infect Dis 2014; 59: S335\u20139. 10.1093\/cid\/ciu612https:\/\/doi.org\/10.1093\/cid\/ciu612"},{"key":"B10","series-title":"Medicina (Kaunas)","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/medicina60010088","article-title":"Stenotrophomonas maltophilia infections in haematological malignancies and hematopoietic stem cell transplantation: a case series including cefiderocol-based regimens","volume":"60","author":"Lupia T","year":"2024","unstructured":"Lupia T, Carnevale-Schianca F, Vita D, Busca A, Caravelli D, Cris\u00e0 E, et al. Stenotrophomonas maltophilia infections in haematological malignancies and hematopoietic stem cell transplantation: a case series including cefiderocol-based regimens. Medicina (Kaunas) 2024; 60: 88. 10.3390\/medicina60010088https:\/\/doi.org\/10.3390\/medicina60010088"},{"key":"B11","series-title":"Ann Hematol","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00277-024-05686-z","article-title":"Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population","volume":"103","author":"Gill EL","year":"2024","unstructured":"Gill EL, Gill CM, McEvoy C. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Ann Hematol 2024; 103: 1745\u201352. 10.1007\/s00277-024-05686-zhttps:\/\/doi.org\/10.1007\/s00277-024-05686-z"},{"key":"B12","series-title":"Eur J Clin Microbiol Infect Dis","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10096-018-3425-1","article-title":"Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis","volume":"38","author":"Kim SH","year":"2019","unstructured":"Kim SH, Cha MK, Kang CI, Ko JH, Huh K, Cho SY, et al. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis. Eur J Clin Microbiol Infect Dis 2019; 38: 285\u201395. 10.1007\/s10096-018-3425-1https:\/\/doi.org\/10.1007\/s10096-018-3425-1"},{"key":"B13","series-title":"BMC Infect Dis","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12879-021-06420-0","article-title":"Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study","volume":"21","author":"Zhu L","year":"2021","unstructured":"Zhu L, Wang L, Zhang Y, Chen R, Li X, Sun J, et al. Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study. BMC Infect Dis 2021; 21: 723. 10.1186\/s12879-021-06420-0https:\/\/doi.org\/10.1186\/s12879-021-06420-0"},{"key":"B14","series-title":"Infect Drug Resist","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.2147\/IDR.S392804","article-title":"Clinical characteristics, microbiology, and risk factors for mortality of pre-engraftment and post-engraftment bloodstream infection in hematopoietic stem cell transplantation recipients","volume":"15","author":"Chen W","year":"2022","unstructured":"Chen W, Zhao Y, Luo Y, Yu J, Fu H, Lai X, et al. Clinical characteristics, microbiology, and risk factors for mortality of pre-engraftment and post-engraftment bloodstream infection in hematopoietic stem cell transplantation recipients. Infect Drug Resist 2022; 15: 6893\u2013905. 10.2147\/IDR.S392804https:\/\/doi.org\/10.2147\/IDR.S392804"},{"key":"B15","series-title":"Eur J Clin Microbiol Infect Dis","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s10096-025-05217-2","article-title":"Predictors of mortality and progression from colonization to Stenotrophomonas maltophilia bloodstream infection in hematologic disorders: a single-center retrospective study","volume":"44","author":"Bi H","year":"2025","unstructured":"Bi H, Lin Q, Sun Q, Lv Y, Tian Z, Fu X, et al. Predictors of mortality and progression from colonization to Stenotrophomonas maltophilia bloodstream infection in hematologic disorders: a single-center retrospective study. Eur J Clin Microbiol Infect Dis 2025; 44: 2609\u201321. 10.1007\/s10096-025-05217-2https:\/\/doi.org\/10.1007\/s10096-025-05217-2"},{"key":"B16","series-title":"Infect Dis","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/23744235.2018.1531145","article-title":"Stenotrophomonas maltophilia \u2013 a low-grade pathogen with numerous virulence factors","volume":"51","author":"Trifonova A","year":"2019","unstructured":"Trifonova A, Strateva T. Stenotrophomonas maltophilia \u2013 a low-grade pathogen with numerous virulence factors. Infect Dis 2019; 51: 168\u201378. 10.1080\/23744235.2018.1531145https:\/\/doi.org\/10.1080\/23744235.2018.1531145"},{"key":"B17","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/AAC.00795-06","article-title":"aph(3\u2032)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia","volume":"51","author":"Okazaki A","year":"2007","unstructured":"Okazaki A, Avison MB. aph(3\u2032)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2007; 51: 359\u201360. 10.1128\/AAC.00795-06https:\/\/doi.org\/10.1128\/AAC.00795-06"},{"key":"B18","series-title":"Front Microbiol","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fmicb.2015.00658","article-title":"Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia","volume":"6","author":"S\u00e1nchez MB","year":"2015","unstructured":"S\u00e1nchez MB. Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Front Microbiol 2015; 6: 658. 10.3389\/fmicb.2015.00658https:\/\/doi.org\/10.3389\/fmicb.2015.00658"},{"key":"B19","series-title":"Front Microbiol","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fmicb.2019.01191","article-title":"Characterization of phenotypic and genotypic diversity of Stenotrophomonas maltophilia strains isolated from selected hospitals in Iran","volume":"10","author":"Bostanghadiri N","year":"2019","unstructured":"Bostanghadiri N, Ghalavand Z, Fallah F, Yadegar A, Ardebili A, Tarashi S, et al. Characterization of phenotypic and genotypic diversity of Stenotrophomonas maltophilia strains isolated from selected hospitals in Iran. Front Microbiol 2019; 10: 1191. 10.3389\/fmicb.2019.01191https:\/\/doi.org\/10.3389\/fmicb.2019.01191"},{"key":"B20","series-title":"New Microbes New Infect","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nmni.2015.04.009","article-title":"Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr","volume":"7","author":"Kanamori H","year":"2015","unstructured":"Kanamori H, Yano H, Tanouchi A, Kakuta R, Endo S, Ichimura S, et al. Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr. New Microbes New Infect 2015; 7: 8\u201314. 10.1016\/j.nmni.2015.04.009https:\/\/doi.org\/10.1016\/j.nmni.2015.04.009"},{"key":"B21","series-title":"Clin Microbiol Rev","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke JS","year":"2012","unstructured":"Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012; 25: 2\u201341. 10.1128\/CMR.00019-11https:\/\/doi.org\/10.1128\/CMR.00019-11"},{"key":"B22","series-title":"Front Microbiol","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang YT","year":"2015","unstructured":"Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol 2015; 6: 893. 10.3389\/fmicb.2015.00893https:\/\/doi.org\/10.3389\/fmicb.2015.00893"},{"key":"B23","series-title":"J Chemother","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/1120009X.2019.1620405","article-title":"Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: systematic review","volume":"31","author":"An\u0111elkovi\u0107 MV","year":"2019","unstructured":"An\u0111elkovi\u0107 MV, Jankovi\u0107 SM, Kosti\u0107 MJ, \u017divkovi\u0107 Zari\u0107 RS, Opan\u010dina VD, \u017divi\u0107 M\u017d, et al. Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: systematic review. J Chemother 2019; 31: 297\u2013306. 10.1080\/1120009X.2019.1620405https:\/\/doi.org\/10.1080\/1120009X.2019.1620405"},{"key":"B24","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious diseases society of America guidance on the treatment of AmpC \u03b2-lactamase\u2013producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma PD","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, Van Duin D, Clancy CJ. Infectious diseases society of America guidance on the treatment of AmpC \u03b2-lactamase\u2013producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Clin Infect Dis 2022; 74: 2089\u2013114. 10.1093\/cid\/ciab1013https:\/\/doi.org\/10.1093\/cid\/ciab1013"},{"key":"B25","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma PD","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin Infect Dis 2024; ciae403. 10.1093\/cid\/ciae403https:\/\/doi.org\/10.1093\/cid\/ciae403"},{"key":"B26","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02167-21","article-title":"In vitro time-kill studies of trimethoprim\/sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli using cation-adjusted Mueller-Hinton broth and ISO-sensitest broth","volume":"66","author":"Lasko MJ","year":"2022","unstructured":"Lasko MJ, Gethers ML, Tabor-Rennie JL, Nicolau DP, Kuti JL. In vitro time-kill studies of trimethoprim\/sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli using cation-adjusted Mueller-Hinton broth and ISO-sensitest broth. Antimicrob Agents Chemother 2022; 66: e02167-21. 10.1128\/aac.02167-21https:\/\/doi.org\/10.1128\/aac.02167-21"},{"key":"B27","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/jac\/dkac304","article-title":"Trimethoprim\/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model","volume":"77","author":"Lasko MJ","year":"2022","unstructured":"Lasko MJ, Tabor-Rennie JL, Nicolau DP, Kuti JL. Trimethoprim\/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model. J Antimicrob Chemother 2022; 77: 3187\u201393. 10.1093\/jac\/dkac304https:\/\/doi.org\/10.1093\/jac\/dkac304"},{"key":"B28","series-title":"J Glob Antimicrob Resist","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jgar.2023.02.018","article-title":"Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"34","author":"Dadashi M","year":"2023","unstructured":"Dadashi M, Hajikhani B, Nazarinejad N, Noorisepehr N, Yazdani S, Hashemi A, et al. Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis. J Glob Antimicrob Resist 2023; 34: 253\u201367. 10.1016\/j.jgar.2023.02.018https:\/\/doi.org\/10.1016\/j.jgar.2023.02.018"},{"key":"B29","series-title":"Ann Lab Med","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3343\/alm.2015.35.2.246","article-title":"The sul1 gene in Stenotrophomonas maltophilia with high-level resistance to trimethoprim\/sulfamethoxazole","volume":"35","author":"Chung HS","year":"2015","unstructured":"Chung HS, Kim K, Hong SS, Hong SG, Lee K, Chong Y. The sul1 gene in Stenotrophomonas maltophilia with high-level resistance to trimethoprim\/sulfamethoxazole. Ann Lab Med 2015; 35: 246\u20139. 10.3343\/alm.2015.35.2.246https:\/\/doi.org\/10.3343\/alm.2015.35.2.246"},{"key":"B30","series-title":"PLoS One","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157693","article-title":"Increase in the prevalence of resistance determinants to trimethoprim\/sulfamethoxazole in clinical Stenotrophomonas maltophilia isolates in China","volume":"11","author":"Hu LF","year":"2016","unstructured":"Hu LF, Chen GS, Kong QX, Gao LP, Chen X, Ye Y, et al. Increase in the prevalence of resistance determinants to trimethoprim\/sulfamethoxazole in clinical Stenotrophomonas maltophilia isolates in China. PLoS One 2016; 11: e0157693. 10.1371\/journal.pone.0157693https:\/\/doi.org\/10.1371\/journal.pone.0157693"},{"key":"B31","series-title":"mBio","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00405-19","article-title":"Population structure, molecular epidemiology, and \u03b2-lactamase diversity among Stenotrophomonas maltophilia isolates in the United States","volume":"10","author":"Mojica MF","year":"2019","unstructured":"Mojica MF, Rutter JD, Taracila M, Abriata LA, Fouts DE, Papp-Wallace KM, et al. Population structure, molecular epidemiology, and \u03b2-lactamase diversity among Stenotrophomonas maltophilia isolates in the United States. mBio 2019; 10: e00405-19. 10.1128\/mBio.00405-19https:\/\/doi.org\/10.1128\/mBio.00405-19"},{"key":"B32","series-title":"Front Microbiol","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1424241","article-title":"Molecular epidemiology, genetic diversity, antibiotic resistance and pathogenicity of Stenotrophomonas maltophilia complex from bacteremia patients in a tertiary hospital in China for nine years","volume":"15","author":"Wang L","year":"2024","unstructured":"Wang L, Wang Y, Ye K, Qiu X, Zhao Q, Ye L, et al. Molecular epidemiology, genetic diversity, antibiotic resistance and pathogenicity of Stenotrophomonas maltophilia complex from bacteremia patients in a tertiary hospital in China for nine years. Front Microbiol 2024; 15: 1424241. 10.3389\/fmicb.2024.1424241https:\/\/doi.org\/10.3389\/fmicb.2024.1424241"},{"issue":"12","key":"B33","series-title":"Int J Syst Evol Microbiol","doi-asserted-by":"publisher","DOI":"10.1099\/ijsem.0.006602","article-title":"Expanding the Stenotrophomonas maltophilia complex: phylogenomic insights, proposal of Stenotrophomonas forensis sp. nov. and reclassification of two Pseudomonas species","volume":"74","author":"Nguyen SV","year":"2024","unstructured":"Nguyen SV, Edwards D, Vaughn EL, Escobar V, Ali S, Doss JH, et al. Expanding the Stenotrophomonas maltophilia complex: phylogenomic insights, proposal of Stenotrophomonas forensis sp. nov. and reclassification of two Pseudomonas species. Int J Syst Evol Microbiol 2024; 74(12). 10.1099\/ijsem.0.006602https:\/\/doi.org\/10.1099\/ijsem.0.006602"},{"key":"B34","series-title":"BMC Bioinform","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12859-024-06030-y","article-title":"DFAST_QC: quality assessment and taxonomic identification tool for prokaryotic genomes","volume":"26","author":"Elmanzalawi M","year":"2025","unstructured":"Elmanzalawi M, Fujisawa T, Mori H, Nakamura Y, Tanizawa Y. DFAST_QC: quality assessment and taxonomic identification tool for prokaryotic genomes. BMC Bioinform 2025; 26: 3. 10.1186\/s12859-024-06030-yhttps:\/\/doi.org\/10.1186\/s12859-024-06030-y"},{"key":"B35","article-title":"Breakpoint tables for interpretation of MICs and zone diameters","author":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2025","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters Version 15.0; 2025. Available from: https:\/\/eucast.org [Accessed 8 September 2025]."},{"key":"B36","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2024","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 34th ed. CLSI supplement M100 (ISBN 978-1-68440-220-5 [Print]; ISBN 978-1-68440-221-2 [Electronic]). USA: Clinical and Laboratory Standards Institute; 2024."},{"key":"B37","series-title":"Nucleic Acids Res","doi-asserted-by":"publisher","first-page":"W345","DOI":"10.1093\/nar\/gkac247","article-title":"The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update","volume":"50","author":"The Galaxy Community","year":"2022","unstructured":"The Galaxy Community, Afgan E, Nekrutenko A, Gr\u00fcning BA, Blankenberg D, Goecks J, et al. The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res 2022; 50: W345\u201351. 10.1093\/nar\/gkac247https:\/\/doi.org\/10.1093\/nar\/gkac247"},{"key":"B38","series-title":"J Bacteriol","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1128\/JB.00892-08","article-title":"A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure","volume":"191","author":"Kaiser S","year":"2009","unstructured":"Kaiser S, Biehler K, Jonas D. A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure. J Bacteriol 2009; 191: 2934\u201343. 10.1128\/JB.00892-08https:\/\/doi.org\/10.1128\/JB.00892-08"},{"key":"B39","series-title":"Bioinformatics","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","article-title":"Prokka: rapid prokaryotic genome annotation","volume":"30","author":"Seemann T","year":"2014","unstructured":"Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014; 30: 2068\u20139. 10.1093\/bioinformatics\/btu153https:\/\/doi.org\/10.1093\/bioinformatics\/btu153"},{"key":"B40","series-title":"Bioinformatics","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1093\/bioinformatics\/btv421","article-title":"Roary: rapid large-scale prokaryote pan genome analysis","volume":"31","author":"Page AJ","year":"2015","unstructured":"Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31: 3691\u20133. 10.1093\/bioinformatics\/btv421https:\/\/doi.org\/10.1093\/bioinformatics\/btv421"},{"key":"B41","series-title":"Bioinformatics","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/bioinformatics\/btu033","article-title":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies","volume":"30","author":"Stamatakis A","year":"2014","unstructured":"Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014; 30: 1312\u20133. 10.1093\/bioinformatics\/btu033https:\/\/doi.org\/10.1093\/bioinformatics\/btu033"},{"key":"B42","series-title":"Nucleic Acids Res","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic I","year":"2024","unstructured":"Letunic I, Bork P. Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res 2024; 52: W78\u201382. 10.1093\/nar\/gkae268https:\/\/doi.org\/10.1093\/nar\/gkae268"},{"key":"B43","series-title":"Rambam Maimonides Med J","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10162","article-title":"Hematopoietic stem cell transplantation \u2013 50 years of evolution and future perspectives","volume":"5","author":"Henig I","year":"2014","unstructured":"Henig I, Zuckerman T. Hematopoietic stem cell transplantation \u2013 50 years of evolution and future perspectives. Rambam Maimonides Med J 2014; 5: e0028. 10.5041\/RMMJ.10162https:\/\/doi.org\/10.5041\/RMMJ.10162"},{"key":"B44","series-title":"Bioengineering","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/bioengineering10020176","article-title":"Hematopoietic stem cell transplantation for the treatment of autoimmune neurological diseases: an update","volume":"10","author":"Mariottini A","year":"2023","unstructured":"Mariottini A, Bulgarini G, Cornacchini S, Damato V, Saccardi R, Massacesi L. Hematopoietic stem cell transplantation for the treatment of autoimmune neurological diseases: an update. Bioengineering 2023; 10: 176. 10.3390\/bioengineering10020176https:\/\/doi.org\/10.3390\/bioengineering10020176"},{"key":"B45","series-title":"F1000Research","doi-asserted-by":"publisher","first-page":"870","DOI":"10.12688\/f1000research.11233.1","article-title":"Recent advances in hematopoietic stem cell transplantation","volume":"6","author":"Norkin M","year":"2017","unstructured":"Norkin M, Wingard JR. Recent advances in hematopoietic stem cell transplantation. F1000Research 2017; 6: 870. 10.12688\/f1000research.11233.1https:\/\/doi.org\/10.12688\/f1000research.11233.1"},{"key":"B46","series-title":"Indian J Hematol Blood Transfus","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s12288-023-01645-2","article-title":"Incidence, risk factors and outcome of bloodstream infections in patients after hematopoietic stem-cell transplantation: a single center study","volume":"39","author":"Niyazi D","year":"2023","unstructured":"Niyazi D, Micheva I, Dokova K, Stoeva T. Incidence, risk factors and outcome of bloodstream infections in patients after hematopoietic stem-cell transplantation: a single center study. Indian J Hematol Blood Transfus 2023; 39: 610\u20134. 10.1007\/s12288-023-01645-2https:\/\/doi.org\/10.1007\/s12288-023-01645-2"},{"key":"B47","series-title":"J Hosp Infect","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jhin.2018.03.004","article-title":"Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization","volume":"100","author":"Ferreira AM","year":"2018","unstructured":"Ferreira AM, Moreira F, Guimaraes T, Spad\u00e3o F, Ramos JF, Batista MV, et al. Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization. J Hosp Infect 2018; 100: 83\u201391. 10.1016\/j.jhin.2018.03.004https:\/\/doi.org\/10.1016\/j.jhin.2018.03.004"},{"key":"B48","series-title":"Sci Rep","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82589-z","article-title":"Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of autologous stem cell transplantation in multiple myeloma","volume":"14","author":"Jasi\u0144ski M","year":"2024","unstructured":"Jasi\u0144ski M, Bili\u0144ski J, Maciejewska M, Ostrowska K, Rusicka-Krzewska P, Konarski W, et al. Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of autologous stem cell transplantation in multiple myeloma. Sci Rep 2024; 14: 31221. 10.1038\/s41598-024-82589-zhttps:\/\/doi.org\/10.1038\/s41598-024-82589-z"},{"key":"B49","series-title":"Acta Microbiol Immunol Hung","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1556\/030.2025.02730","article-title":"Prevalence of intestinal colonization by multidrug-resistant bacteria and related bloodstream infections in patients with hematological malignancies","volume":"72","author":"Stoeva T","year":"2025","unstructured":"Stoeva T, Niyazi D, Stoev L, Dokova K. Prevalence of intestinal colonization by multidrug-resistant bacteria and related bloodstream infections in patients with hematological malignancies. Acta Microbiol Immunol Hung 2025; 72: 341\u20139. 10.1556\/030.2025.02730https:\/\/doi.org\/10.1556\/030.2025.02730"},{"key":"B50","series-title":"Antibiotics","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/antibiotics13100920","article-title":"Prevalence and molecular epidemiology of intestinal colonization by multidrug-resistant bacteria among hematopoietic stem-cell transplantation recipients: a Bulgarian single-center study","volume":"13","author":"Niyazi D","year":"2024","unstructured":"Niyazi D, Vergiev S, Markovska R, Stoeva T. Prevalence and molecular epidemiology of intestinal colonization by multidrug-resistant bacteria among hematopoietic stem-cell transplantation recipients: a Bulgarian single-center study. Antibiotics 2024; 13: 920. 10.3390\/antibiotics13100920https:\/\/doi.org\/10.3390\/antibiotics13100920"},{"key":"B51","series-title":"Clin Transpl","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ctr.12356","article-title":"Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single\u2010center experience","volume":"28","author":"Shiratori S","year":"2014","unstructured":"Shiratori S, Wakasa K, Okada K, Sugita J, Akizawa K, Shigematsu A, et al. Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single\u2010center experience. Clin Transpl 2014; 28: 656\u201361. 10.1111\/ctr.12356https:\/\/doi.org\/10.1111\/ctr.12356"},{"key":"B52","series-title":"PLoS One","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201169.53","article-title":"Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival","volume":"13","author":"Scheich S","year":"2018","unstructured":"Scheich S, Koenig R, Wilke AC, Lindner S, Reinheimer C, Wichelhaus TA, et al. Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival. PLoS One 2018; 13: e0201169. 10.1371\/journal.pone.0201169.53https:\/\/doi.org\/10.1371\/journal.pone.0201169.53"},{"key":"B53","series-title":"Pharmaceuticals","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/ph16030466","article-title":"Cost-effectiveness of targeted prophylaxis among allogenic stem cell transplant recipients","volume":"16","author":"Shbaklo N","year":"2023","unstructured":"Shbaklo N, Vicentini C, Busca A, Giaccone L, Dellacasa C, Dogliotti I, et al. Cost-effectiveness of targeted prophylaxis among allogenic stem cell transplant recipients. Pharmaceuticals 2023; 16: 466. 10.3390\/ph16030466https:\/\/doi.org\/10.3390\/ph16030466"},{"key":"B54","series-title":"Mediterr J Hematol Infect Dis","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2023.022","article-title":"Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study","volume":"15","author":"Urbino I","year":"2023","unstructured":"Urbino I, Frairia C, Busca A, Corcione S, D'Ardia S, Dellacasa CM, et al. Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study. Mediterr J Hematol Infect Dis 2023; 15: e2023022. 10.4084\/MJHID.2023.022https:\/\/doi.org\/10.4084\/MJHID.2023.022"},{"key":"B55","series-title":"Mediterr J Infect Microbes Antimicrob","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4274\/mjima.galenos.2021.2021.52","article-title":"First investigation of OqxAB and plasmid mediated quinolone resistance determinants qnr genes in Stenotrophomonas maltophilia isolates","volume":"10","author":"Tanriverdi \u00c7ayci Y","year":"2021","unstructured":"Tanriverdi \u00c7ayci Y, Biyik I, Birinci A. First investigation of OqxAB and plasmid mediated quinolone resistance determinants qnr genes in Stenotrophomonas maltophilia isolates. Mediterr J Infect Microbes Antimicrob 2021; 10: 52. 10.4274\/mjima.galenos.2021.2021.52https:\/\/doi.org\/10.4274\/mjima.galenos.2021.2021.52"},{"key":"B56","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01436-20","article-title":"In vitro activity and in vivo efficacy of cefiderocol against Stenotrophomonas maltophilia","volume":"65","author":"Nakamura R","year":"2021","unstructured":"Nakamura R, Oota M, Matsumoto S, Sato T, Yamano Y. In vitro activity and in vivo efficacy of cefiderocol against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2021; 65: e01436-20. 10.1128\/AAC.01436-20https:\/\/doi.org\/10.1128\/AAC.01436-20"},{"key":"B57","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00559-20","article-title":"Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia","volume":"64","author":"Biagi M","year":"2020","unstructured":"Biagi M, Vialichka A, Jurkovic M, Wu T, Shajee A, Lee M, et al. Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2020; 64: e00559-20. 10.1128\/AAC.00559-20https:\/\/doi.org\/10.1128\/AAC.00559-20"},{"key":"B58","series-title":"Antibiotics","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/antibiotics12050910","article-title":"Stenotrophomonas maltophilia infections: a systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options","volume":"12","author":"Maraolo AE","year":"2023","unstructured":"Maraolo AE, Licciardi F, Gentile I, Saracino A, Belati A, Bavaro DF. Stenotrophomonas maltophilia infections: a systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options. Antibiotics 2023; 12: 910. 10.3390\/antibiotics12050910https:\/\/doi.org\/10.3390\/antibiotics12050910"},{"key":"B59","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-19","article-title":"In vitro activity of minocycline against U.S. isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: results from the SENTRY antimicrobial surveillance program, 2014 to 2018","volume":"63","author":"Flamm RK","year":"2019","unstructured":"Flamm RK, Shortridge D, Castanheira M, Sader HS, Pfaller MA. In vitro activity of minocycline against U.S. isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: results from the SENTRY antimicrobial surveillance program, 2014 to 2018. Antimicrob Agents Chemother 2019; 63: e01154-19. 10.1128\/AAC.01154-19https:\/\/doi.org\/10.1128\/AAC.01154-19"},{"key":"B60","series-title":"Int J Infect Dis","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107803","article-title":"Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018\u20132023)","volume":"153","author":"Sader HS","year":"2025","unstructured":"Sader HS, Mendes RE, Doyle TB, Winkler ML, Castanheira M. Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018\u20132023). Int J Infect Dis 2025; 153: 107803. 10.1016\/j.ijid.2025.107803https:\/\/doi.org\/10.1016\/j.ijid.2025.107803"},{"key":"B61","series-title":"J Microbiol Methods","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mimet.2018.12.002","article-title":"Multiplex real-time PCR assays to detect Stenotrophomonas maltophilia carrying sul1, sul2, and sul3 genes","volume":"156","author":"Li S","year":"2019","unstructured":"Li S, Peng Y, Rui Y. Multiplex real-time PCR assays to detect Stenotrophomonas maltophilia carrying sul1, sul2, and sul3 genes. J Microbiol Methods 2019; 156: 52\u20139. 10.1016\/j.mimet.2018.12.002https:\/\/doi.org\/10.1016\/j.mimet.2018.12.002"},{"key":"B62","series-title":"Emerg Infect Dis","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3201\/eid1304.061378","article-title":"Global emergence of trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes","volume":"13","author":"Toleman MA","year":"2007","unstructured":"Toleman MA, Bennett PM, Bennett DMC, Jones RN, Walsh TR. Global emergence of trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 2007; 13: 559\u201365. 10.3201\/eid1304.061378https:\/\/doi.org\/10.3201\/eid1304.061378"},{"key":"B63","series-title":"Int J Antimicrob Agents","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijantimicag.2010.10.025","article-title":"Stenotrophomonas maltophilia resistance to trimethoprim\/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron","volume":"37","author":"Hu LF","year":"2011","unstructured":"Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, et al. Stenotrophomonas maltophilia resistance to trimethoprim\/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents 2011; 37: 230\u20134. 10.1016\/j.ijantimicag.2010.10.025https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.10.025"},{"key":"B64","series-title":"Indian J Med Microbiol","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2024.100612","article-title":"Evaluation of the presence of integrons, sul and smqnr genes and the prevalence of antibiotic resistance in Stenotrophomonas maltophilia clinical isolates","volume":"49","author":"Mokhtari Bibalan M","year":"2024","unstructured":"Mokhtari Bibalan M, Mojtahedi A, Mahdieh N, Jafari A, Atrkar Roushan Z, Arya MJ. Evaluation of the presence of integrons, sul and smqnr genes and the prevalence of antibiotic resistance in Stenotrophomonas maltophilia clinical isolates. Indian J Med Microbiol 2024; 49: 100612. 10.1016\/j.ijmmb.2024.100612https:\/\/doi.org\/10.1016\/j.ijmmb.2024.100612"},{"key":"B65","series-title":"Infect Dis (Lond)","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/23744235.2020.1792545","article-title":"Characterization of an extensively drug-resistant Stenotrophomonas maltophilia clinical isolate with strong biofilm formation ability from Bulgaria","volume":"52","author":"Strateva T","year":"2020","unstructured":"Strateva T, Trifonova A, Savov E, Mitov I, Peykov S. Characterization of an extensively drug-resistant Stenotrophomonas maltophilia clinical isolate with strong biofilm formation ability from Bulgaria. Infect Dis (Lond) 2020; 52: 841\u20135. 10.1080\/23744235.2020.1792545https:\/\/doi.org\/10.1080\/23744235.2020.1792545"},{"key":"B66","series-title":"Microbiol Resour Announc","doi-asserted-by":"publisher","DOI":"10.1128\/mra.00091-23","article-title":"Whole-genome sequencing of 11 high-risk clone ST111 Pseudomonas aeruginosa isolates from French hospitals","volume":"12","author":"Anbo M","year":"2023","unstructured":"Anbo M, Chichkova MAT, Gen\u00e7ay YE, Salazar A, Jeannot K, Jelsbak L. Whole-genome sequencing of 11 high-risk clone ST111 Pseudomonas aeruginosa isolates from French hospitals. Microbiol Resour Announc 2023; 12: e00091-23. 10.1128\/mra.00091-23https:\/\/doi.org\/10.1128\/mra.00091-23"},{"key":"B67","series-title":"Front Microbiol","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.611246","article-title":"Within-host microevolution of Pseudomonas aeruginosa urinary isolates: a seven-patient longitudinal genomic and phenotypic study","volume":"11","author":"Cottalorda A","year":"2021","unstructured":"Cottalorda A, Leoz M, Dahyot S, Gravey F, Grand M, Froidure T, et al. Within-host microevolution of Pseudomonas aeruginosa urinary isolates: a seven-patient longitudinal genomic and phenotypic study. Front Microbiol 2021; 11: 611246. 10.3389\/fmicb.2020.611246https:\/\/doi.org\/10.3389\/fmicb.2020.611246"},{"key":"B68","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1128\/AAC.42.10.2557","article-title":"Characterization of In40 of Enterobacter aerogenes BM2688, a class 1 integron with two new gene cassettes, cmlA2 and qacF","volume":"42","author":"Ploy MC","year":"1998","unstructured":"Ploy MC, Courvalin P, Lambert T. Characterization of In40 of Enterobacter aerogenes BM2688, a class 1 integron with two new gene cassettes, cmlA2 and qacF. Antimicrob Agents Chemother 1998; 42: 2557\u201363. 10.1128\/AAC.42.10.2557https:\/\/doi.org\/10.1128\/AAC.42.10.2557"},{"key":"B69","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00724-21","article-title":"Exploring the global spread of Klebsiella grimontii isolates possessing blaVIM-1 and mcr-9","volume":"65","author":"Campos-Madueno EI","year":"2021","unstructured":"Campos-Madueno EI, Moser AI, Risch M, Bodmer T, Endimiani A. Exploring the global spread of Klebsiella grimontii isolates possessing blaVIM-1 and mcr-9. Antimicrob Agents Chemother 2021; 65: e00724-21. 10.1128\/AAC.00724-21https:\/\/doi.org\/10.1128\/AAC.00724-21"},{"key":"B70","series-title":"Emerg Infect Dis","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3201\/eid2406.171648","article-title":"Genomic epidemiology of global carbapenemase-producing Enterobacter spp., 2008\u20132014","volume":"24","author":"Peirano G","year":"2018","unstructured":"Peirano G, Matsumura Y, Adams MD, Bradford P, Motyl M, Chen L, et al. Genomic epidemiology of global carbapenemase-producing Enterobacter spp., 2008\u20132014. Emerg Infect Dis 2018; 24: 1010\u20139. 10.3201\/eid2406.171648https:\/\/doi.org\/10.3201\/eid2406.171648"},{"key":"B1","series-title":"Clin Microbiol Rev","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00030-19","article-title":"Advances in the microbiology of Stenotrophomonas maltophilia","volume":"34","author":"Brooke JS","year":"2021","unstructured":"Brooke JS. Advances in the microbiology of Stenotrophomonas maltophilia. Clin Microbiol Rev 2021; 34: e00030-19. 10.1128\/CMR.00030-19https:\/\/doi.org\/10.1128\/CMR.00030-19"},{"key":"B2","series-title":"Front Cell Infect Microbiol","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1325379","article-title":"Stenotrophomonas maltophilia complex: insights into evolutionary relationships, global distribution and pathogenicity","volume":"13","author":"Li K","year":"2024","unstructured":"Li K, Yu K, Huang Z, Liu X, Mei L, Ren X, et al. Stenotrophomonas maltophilia complex: insights into evolutionary relationships, global distribution and pathogenicity. Front Cell Infect Microbiol 2024; 13: 1325379. 10.3389\/fcimb.2023.1325379https:\/\/doi.org\/10.3389\/fcimb.2023.1325379"},{"key":"B3","series-title":"Biofilm","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2025.100253","article-title":"Role of SMF-1 and Cbl pili in Stenotrophomonas maltophilia biofilm formation","volume":"9","author":"Bhaumik R","year":"2025","unstructured":"Bhaumik R, Beard A, Harrigan O, Ramos-Hegazy L, Mattoo S, Anderson GG. Role of SMF-1 and Cbl pili in Stenotrophomonas maltophilia biofilm formation. Biofilm 2025; 9: 100253. 10.1016\/j.bioflm.2025.100253https:\/\/doi.org\/10.1016\/j.bioflm.2025.100253"},{"key":"B4","series-title":"Acta Microbiol Immunol Hung","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1556\/030.2023.01920","article-title":"Analysis of biofilm formation in nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria: an 11-year study (2011\u20132022)","volume":"70","author":"Strateva T","year":"2023","unstructured":"Strateva T, Trifonova A, Sirakov I, Borisova D, Stancheva M, Keuleyan E, et al. Analysis of biofilm formation in nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria: an 11-year study (2011\u20132022). Acta Microbiol Immunol Hung 2023; 70: 11\u201321. 10.1556\/030.2023.01920https:\/\/doi.org\/10.1556\/030.2023.01920"},{"key":"B5","series-title":"CMI Commun","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmicom.2025.105082","article-title":"Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review","volume":"2","author":"Turnidge J","year":"2025","unstructured":"Turnidge J, Gatermann S, Kahlmeter G, Cant\u00f3n R, Wootton M, Giske CG. Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review. CMI Commun 2025; 2: 105082. 10.1016\/j.cmicom.2025.105082https:\/\/doi.org\/10.1016\/j.cmicom.2025.105082"},{"key":"B6","series-title":"Acta Microbiol Immunol Hung","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1556\/030.2025.02578","article-title":"Efflux pump systems as key contributors to multidrug resistance in Stenotrophomonas maltophilia: physiological roles and gene regulation","volume":"72","author":"Vattanaviboon P","year":"2025","unstructured":"Vattanaviboon P, Dulyayangkul P, Mongkolsuk S, Charoenlap N. Efflux pump systems as key contributors to multidrug resistance in Stenotrophomonas maltophilia: physiological roles and gene regulation. Acta Microbiol Immunol Hung 2025; 72: 81\u201392. 10.1556\/030.2025.02578https:\/\/doi.org\/10.1556\/030.2025.02578"},{"key":"B7","series-title":"Antibiotics","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/antibiotics13070577","article-title":"Stenotrophomonas maltophilia: the landscape in critically ill patients and optimising management approaches","volume":"13","author":"Carbonell N","year":"2024","unstructured":"Carbonell N, Oltra MR, Clari M\u00c1. Stenotrophomonas maltophilia: the landscape in critically ill patients and optimising management approaches. Antibiotics 2024; 13: 577. 10.3390\/antibiotics13070577https:\/\/doi.org\/10.3390\/antibiotics13070577"},{"key":"B8","series-title":"Chest","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1378\/chest.15-0676","article-title":"Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis","volume":"149","author":"Salsgiver EL","year":"2016","unstructured":"Salsgiver EL, Fink AK, Knapp EA, LiPuma JJ, Olivier KN, Marshall BC, et al. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis. Chest 2016; 149: 390\u2013400. 10.1378\/chest.15-0676https:\/\/doi.org\/10.1378\/chest.15-0676"},{"key":"B9","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1093\/cid\/ciu612","article-title":"Antibiotic-resistant Gram-negative bacterial infections in patients with cancer","volume":"59","author":"Perez F","year":"2014","unstructured":"Perez F, Adachi J, Bonomo RA. Antibiotic-resistant Gram-negative bacterial infections in patients with cancer. Clin Infect Dis 2014; 59: S335\u20139. 10.1093\/cid\/ciu612https:\/\/doi.org\/10.1093\/cid\/ciu612"},{"key":"B10","series-title":"Medicina (Kaunas)","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/medicina60010088","article-title":"Stenotrophomonas maltophilia infections in haematological malignancies and hematopoietic stem cell transplantation: a case series including cefiderocol-based regimens","volume":"60","author":"Lupia T","year":"2024","unstructured":"Lupia T, Carnevale-Schianca F, Vita D, Busca A, Caravelli D, Cris\u00e0 E, et al. Stenotrophomonas maltophilia infections in haematological malignancies and hematopoietic stem cell transplantation: a case series including cefiderocol-based regimens. Medicina (Kaunas) 2024; 60: 88. 10.3390\/medicina60010088https:\/\/doi.org\/10.3390\/medicina60010088"},{"key":"B11","series-title":"Ann Hematol","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00277-024-05686-z","article-title":"Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population","volume":"103","author":"Gill EL","year":"2024","unstructured":"Gill EL, Gill CM, McEvoy C. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Ann Hematol 2024; 103: 1745\u201352. 10.1007\/s00277-024-05686-zhttps:\/\/doi.org\/10.1007\/s00277-024-05686-z"},{"key":"B12","series-title":"Eur J Clin Microbiol Infect Dis","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10096-018-3425-1","article-title":"Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis","volume":"38","author":"Kim SH","year":"2019","unstructured":"Kim SH, Cha MK, Kang CI, Ko JH, Huh K, Cho SY, et al. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis. Eur J Clin Microbiol Infect Dis 2019; 38: 285\u201395. 10.1007\/s10096-018-3425-1https:\/\/doi.org\/10.1007\/s10096-018-3425-1"},{"key":"B13","series-title":"BMC Infect Dis","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12879-021-06420-0","article-title":"Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study","volume":"21","author":"Zhu L","year":"2021","unstructured":"Zhu L, Wang L, Zhang Y, Chen R, Li X, Sun J, et al. Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study. BMC Infect Dis 2021; 21: 723. 10.1186\/s12879-021-06420-0https:\/\/doi.org\/10.1186\/s12879-021-06420-0"},{"key":"B14","series-title":"Infect Drug Resist","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.2147\/IDR.S392804","article-title":"Clinical characteristics, microbiology, and risk factors for mortality of pre-engraftment and post-engraftment bloodstream infection in hematopoietic stem cell transplantation recipients","volume":"15","author":"Chen W","year":"2022","unstructured":"Chen W, Zhao Y, Luo Y, Yu J, Fu H, Lai X, et al. Clinical characteristics, microbiology, and risk factors for mortality of pre-engraftment and post-engraftment bloodstream infection in hematopoietic stem cell transplantation recipients. Infect Drug Resist 2022; 15: 6893\u2013905. 10.2147\/IDR.S392804https:\/\/doi.org\/10.2147\/IDR.S392804"},{"key":"B15","series-title":"Eur J Clin Microbiol Infect Dis","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s10096-025-05217-2","article-title":"Predictors of mortality and progression from colonization to Stenotrophomonas maltophilia bloodstream infection in hematologic disorders: a single-center retrospective study","volume":"44","author":"Bi H","year":"2025","unstructured":"Bi H, Lin Q, Sun Q, Lv Y, Tian Z, Fu X, et al. Predictors of mortality and progression from colonization to Stenotrophomonas maltophilia bloodstream infection in hematologic disorders: a single-center retrospective study. Eur J Clin Microbiol Infect Dis 2025; 44: 2609\u201321. 10.1007\/s10096-025-05217-2https:\/\/doi.org\/10.1007\/s10096-025-05217-2"},{"key":"B16","series-title":"Infect Dis","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/23744235.2018.1531145","article-title":"Stenotrophomonas maltophilia \u2013 a low-grade pathogen with numerous virulence factors","volume":"51","author":"Trifonova A","year":"2019","unstructured":"Trifonova A, Strateva T. Stenotrophomonas maltophilia \u2013 a low-grade pathogen with numerous virulence factors. Infect Dis 2019; 51: 168\u201378. 10.1080\/23744235.2018.1531145https:\/\/doi.org\/10.1080\/23744235.2018.1531145"},{"key":"B17","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/AAC.00795-06","article-title":"aph(3\u2032)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia","volume":"51","author":"Okazaki A","year":"2007","unstructured":"Okazaki A, Avison MB. aph(3\u2032)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2007; 51: 359\u201360. 10.1128\/AAC.00795-06https:\/\/doi.org\/10.1128\/AAC.00795-06"},{"key":"B18","series-title":"Front Microbiol","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fmicb.2015.00658","article-title":"Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia","volume":"6","author":"S\u00e1nchez MB","year":"2015","unstructured":"S\u00e1nchez MB. Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Front Microbiol 2015; 6: 658. 10.3389\/fmicb.2015.00658https:\/\/doi.org\/10.3389\/fmicb.2015.00658"},{"key":"B19","series-title":"Front Microbiol","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fmicb.2019.01191","article-title":"Characterization of phenotypic and genotypic diversity of Stenotrophomonas maltophilia strains isolated from selected hospitals in Iran","volume":"10","author":"Bostanghadiri N","year":"2019","unstructured":"Bostanghadiri N, Ghalavand Z, Fallah F, Yadegar A, Ardebili A, Tarashi S, et al. Characterization of phenotypic and genotypic diversity of Stenotrophomonas maltophilia strains isolated from selected hospitals in Iran. Front Microbiol 2019; 10: 1191. 10.3389\/fmicb.2019.01191https:\/\/doi.org\/10.3389\/fmicb.2019.01191"},{"key":"B20","series-title":"New Microbes New Infect","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nmni.2015.04.009","article-title":"Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr","volume":"7","author":"Kanamori H","year":"2015","unstructured":"Kanamori H, Yano H, Tanouchi A, Kakuta R, Endo S, Ichimura S, et al. Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr. New Microbes New Infect 2015; 7: 8\u201314. 10.1016\/j.nmni.2015.04.009https:\/\/doi.org\/10.1016\/j.nmni.2015.04.009"},{"key":"B21","series-title":"Clin Microbiol Rev","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke JS","year":"2012","unstructured":"Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012; 25: 2\u201341. 10.1128\/CMR.00019-11https:\/\/doi.org\/10.1128\/CMR.00019-11"},{"key":"B22","series-title":"Front Microbiol","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang YT","year":"2015","unstructured":"Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol 2015; 6: 893. 10.3389\/fmicb.2015.00893https:\/\/doi.org\/10.3389\/fmicb.2015.00893"},{"key":"B23","series-title":"J Chemother","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/1120009X.2019.1620405","article-title":"Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: systematic review","volume":"31","author":"An\u0111elkovi\u0107 MV","year":"2019","unstructured":"An\u0111elkovi\u0107 MV, Jankovi\u0107 SM, Kosti\u0107 MJ, \u017divkovi\u0107 Zari\u0107 RS, Opan\u010dina VD, \u017divi\u0107 M\u017d, et al. Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: systematic review. J Chemother 2019; 31: 297\u2013306. 10.1080\/1120009X.2019.1620405https:\/\/doi.org\/10.1080\/1120009X.2019.1620405"},{"key":"B24","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious diseases society of America guidance on the treatment of AmpC \u03b2-lactamase\u2013producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma PD","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, Van Duin D, Clancy CJ. Infectious diseases society of America guidance on the treatment of AmpC \u03b2-lactamase\u2013producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Clin Infect Dis 2022; 74: 2089\u2013114. 10.1093\/cid\/ciab1013https:\/\/doi.org\/10.1093\/cid\/ciab1013"},{"key":"B25","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma PD","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin Infect Dis 2024; ciae403. 10.1093\/cid\/ciae403https:\/\/doi.org\/10.1093\/cid\/ciae403"},{"key":"B26","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02167-21","article-title":"In vitro time-kill studies of trimethoprim\/sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli using cation-adjusted Mueller-Hinton broth and ISO-sensitest broth","volume":"66","author":"Lasko MJ","year":"2022","unstructured":"Lasko MJ, Gethers ML, Tabor-Rennie JL, Nicolau DP, Kuti JL. In vitro time-kill studies of trimethoprim\/sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli using cation-adjusted Mueller-Hinton broth and ISO-sensitest broth. Antimicrob Agents Chemother 2022; 66: e02167-21. 10.1128\/aac.02167-21https:\/\/doi.org\/10.1128\/aac.02167-21"},{"key":"B27","series-title":"J Antimicrob Chemother","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/jac\/dkac304","article-title":"Trimethoprim\/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model","volume":"77","author":"Lasko MJ","year":"2022","unstructured":"Lasko MJ, Tabor-Rennie JL, Nicolau DP, Kuti JL. Trimethoprim\/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model. J Antimicrob Chemother 2022; 77: 3187\u201393. 10.1093\/jac\/dkac304https:\/\/doi.org\/10.1093\/jac\/dkac304"},{"key":"B28","series-title":"J Glob Antimicrob Resist","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jgar.2023.02.018","article-title":"Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"34","author":"Dadashi M","year":"2023","unstructured":"Dadashi M, Hajikhani B, Nazarinejad N, Noorisepehr N, Yazdani S, Hashemi A, et al. Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis. J Glob Antimicrob Resist 2023; 34: 253\u201367. 10.1016\/j.jgar.2023.02.018https:\/\/doi.org\/10.1016\/j.jgar.2023.02.018"},{"key":"B29","series-title":"Ann Lab Med","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3343\/alm.2015.35.2.246","article-title":"The sul1 gene in Stenotrophomonas maltophilia with high-level resistance to trimethoprim\/sulfamethoxazole","volume":"35","author":"Chung HS","year":"2015","unstructured":"Chung HS, Kim K, Hong SS, Hong SG, Lee K, Chong Y. The sul1 gene in Stenotrophomonas maltophilia with high-level resistance to trimethoprim\/sulfamethoxazole. Ann Lab Med 2015; 35: 246\u20139. 10.3343\/alm.2015.35.2.246https:\/\/doi.org\/10.3343\/alm.2015.35.2.246"},{"key":"B30","series-title":"PLoS One","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157693","article-title":"Increase in the prevalence of resistance determinants to trimethoprim\/sulfamethoxazole in clinical Stenotrophomonas maltophilia isolates in China","volume":"11","author":"Hu LF","year":"2016","unstructured":"Hu LF, Chen GS, Kong QX, Gao LP, Chen X, Ye Y, et al. Increase in the prevalence of resistance determinants to trimethoprim\/sulfamethoxazole in clinical Stenotrophomonas maltophilia isolates in China. PLoS One 2016; 11: e0157693. 10.1371\/journal.pone.0157693https:\/\/doi.org\/10.1371\/journal.pone.0157693"},{"key":"B31","series-title":"mBio","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00405-19","article-title":"Population structure, molecular epidemiology, and \u03b2-lactamase diversity among Stenotrophomonas maltophilia isolates in the United States","volume":"10","author":"Mojica MF","year":"2019","unstructured":"Mojica MF, Rutter JD, Taracila M, Abriata LA, Fouts DE, Papp-Wallace KM, et al. Population structure, molecular epidemiology, and \u03b2-lactamase diversity among Stenotrophomonas maltophilia isolates in the United States. mBio 2019; 10: e00405-19. 10.1128\/mBio.00405-19https:\/\/doi.org\/10.1128\/mBio.00405-19"},{"key":"B32","series-title":"Front Microbiol","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1424241","article-title":"Molecular epidemiology, genetic diversity, antibiotic resistance and pathogenicity of Stenotrophomonas maltophilia complex from bacteremia patients in a tertiary hospital in China for nine years","volume":"15","author":"Wang L","year":"2024","unstructured":"Wang L, Wang Y, Ye K, Qiu X, Zhao Q, Ye L, et al. Molecular epidemiology, genetic diversity, antibiotic resistance and pathogenicity of Stenotrophomonas maltophilia complex from bacteremia patients in a tertiary hospital in China for nine years. Front Microbiol 2024; 15: 1424241. 10.3389\/fmicb.2024.1424241https:\/\/doi.org\/10.3389\/fmicb.2024.1424241"},{"issue":"12","key":"B33","series-title":"Int J Syst Evol Microbiol","doi-asserted-by":"publisher","DOI":"10.1099\/ijsem.0.006602","article-title":"Expanding the Stenotrophomonas maltophilia complex: phylogenomic insights, proposal of Stenotrophomonas forensis sp. nov. and reclassification of two Pseudomonas species","volume":"74","author":"Nguyen SV","year":"2024","unstructured":"Nguyen SV, Edwards D, Vaughn EL, Escobar V, Ali S, Doss JH, et al. Expanding the Stenotrophomonas maltophilia complex: phylogenomic insights, proposal of Stenotrophomonas forensis sp. nov. and reclassification of two Pseudomonas species. Int J Syst Evol Microbiol 2024; 74(12). 10.1099\/ijsem.0.006602https:\/\/doi.org\/10.1099\/ijsem.0.006602"},{"key":"B34","series-title":"BMC Bioinform","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12859-024-06030-y","article-title":"DFAST_QC: quality assessment and taxonomic identification tool for prokaryotic genomes","volume":"26","author":"Elmanzalawi M","year":"2025","unstructured":"Elmanzalawi M, Fujisawa T, Mori H, Nakamura Y, Tanizawa Y. DFAST_QC: quality assessment and taxonomic identification tool for prokaryotic genomes. BMC Bioinform 2025; 26: 3. 10.1186\/s12859-024-06030-yhttps:\/\/doi.org\/10.1186\/s12859-024-06030-y"},{"key":"B35","article-title":"Breakpoint tables for interpretation of MICs and zone diameters","author":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2025","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters Version 15.0; 2025. Available from: https:\/\/eucast.org [Accessed 8 September 2025]."},{"key":"B36","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2024","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 34th ed. CLSI supplement M100 (ISBN 978-1-68440-220-5 [Print]; ISBN 978-1-68440-221-2 [Electronic]). USA: Clinical and Laboratory Standards Institute; 2024."},{"key":"B37","series-title":"Nucleic Acids Res","doi-asserted-by":"publisher","first-page":"W345","DOI":"10.1093\/nar\/gkac247","article-title":"The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update","volume":"50","author":"The Galaxy Community","year":"2022","unstructured":"The Galaxy Community, Afgan E, Nekrutenko A, Gr\u00fcning BA, Blankenberg D, Goecks J, et al. The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res 2022; 50: W345\u201351. 10.1093\/nar\/gkac247https:\/\/doi.org\/10.1093\/nar\/gkac247"},{"key":"B38","series-title":"J Bacteriol","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1128\/JB.00892-08","article-title":"A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure","volume":"191","author":"Kaiser S","year":"2009","unstructured":"Kaiser S, Biehler K, Jonas D. A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure. J Bacteriol 2009; 191: 2934\u201343. 10.1128\/JB.00892-08https:\/\/doi.org\/10.1128\/JB.00892-08"},{"key":"B39","series-title":"Bioinformatics","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","article-title":"Prokka: rapid prokaryotic genome annotation","volume":"30","author":"Seemann T","year":"2014","unstructured":"Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014; 30: 2068\u20139. 10.1093\/bioinformatics\/btu153https:\/\/doi.org\/10.1093\/bioinformatics\/btu153"},{"key":"B40","series-title":"Bioinformatics","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1093\/bioinformatics\/btv421","article-title":"Roary: rapid large-scale prokaryote pan genome analysis","volume":"31","author":"Page AJ","year":"2015","unstructured":"Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31: 3691\u20133. 10.1093\/bioinformatics\/btv421https:\/\/doi.org\/10.1093\/bioinformatics\/btv421"},{"key":"B41","series-title":"Bioinformatics","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/bioinformatics\/btu033","article-title":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies","volume":"30","author":"Stamatakis A","year":"2014","unstructured":"Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014; 30: 1312\u20133. 10.1093\/bioinformatics\/btu033https:\/\/doi.org\/10.1093\/bioinformatics\/btu033"},{"key":"B42","series-title":"Nucleic Acids Res","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic I","year":"2024","unstructured":"Letunic I, Bork P. Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res 2024; 52: W78\u201382. 10.1093\/nar\/gkae268https:\/\/doi.org\/10.1093\/nar\/gkae268"},{"key":"B43","series-title":"Rambam Maimonides Med J","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10162","article-title":"Hematopoietic stem cell transplantation \u2013 50 years of evolution and future perspectives","volume":"5","author":"Henig I","year":"2014","unstructured":"Henig I, Zuckerman T. Hematopoietic stem cell transplantation \u2013 50 years of evolution and future perspectives. Rambam Maimonides Med J 2014; 5: e0028. 10.5041\/RMMJ.10162https:\/\/doi.org\/10.5041\/RMMJ.10162"},{"key":"B44","series-title":"Bioengineering","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/bioengineering10020176","article-title":"Hematopoietic stem cell transplantation for the treatment of autoimmune neurological diseases: an update","volume":"10","author":"Mariottini A","year":"2023","unstructured":"Mariottini A, Bulgarini G, Cornacchini S, Damato V, Saccardi R, Massacesi L. Hematopoietic stem cell transplantation for the treatment of autoimmune neurological diseases: an update. Bioengineering 2023; 10: 176. 10.3390\/bioengineering10020176https:\/\/doi.org\/10.3390\/bioengineering10020176"},{"key":"B45","series-title":"F1000Research","doi-asserted-by":"publisher","first-page":"870","DOI":"10.12688\/f1000research.11233.1","article-title":"Recent advances in hematopoietic stem cell transplantation","volume":"6","author":"Norkin M","year":"2017","unstructured":"Norkin M, Wingard JR. Recent advances in hematopoietic stem cell transplantation. F1000Research 2017; 6: 870. 10.12688\/f1000research.11233.1https:\/\/doi.org\/10.12688\/f1000research.11233.1"},{"key":"B46","series-title":"Indian J Hematol Blood Transfus","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s12288-023-01645-2","article-title":"Incidence, risk factors and outcome of bloodstream infections in patients after hematopoietic stem-cell transplantation: a single center study","volume":"39","author":"Niyazi D","year":"2023","unstructured":"Niyazi D, Micheva I, Dokova K, Stoeva T. Incidence, risk factors and outcome of bloodstream infections in patients after hematopoietic stem-cell transplantation: a single center study. Indian J Hematol Blood Transfus 2023; 39: 610\u20134. 10.1007\/s12288-023-01645-2https:\/\/doi.org\/10.1007\/s12288-023-01645-2"},{"key":"B47","series-title":"J Hosp Infect","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jhin.2018.03.004","article-title":"Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization","volume":"100","author":"Ferreira AM","year":"2018","unstructured":"Ferreira AM, Moreira F, Guimaraes T, Spad\u00e3o F, Ramos JF, Batista MV, et al. Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization. J Hosp Infect 2018; 100: 83\u201391. 10.1016\/j.jhin.2018.03.004https:\/\/doi.org\/10.1016\/j.jhin.2018.03.004"},{"key":"B48","series-title":"Sci Rep","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82589-z","article-title":"Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of autologous stem cell transplantation in multiple myeloma","volume":"14","author":"Jasi\u0144ski M","year":"2024","unstructured":"Jasi\u0144ski M, Bili\u0144ski J, Maciejewska M, Ostrowska K, Rusicka-Krzewska P, Konarski W, et al. Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of autologous stem cell transplantation in multiple myeloma. Sci Rep 2024; 14: 31221. 10.1038\/s41598-024-82589-zhttps:\/\/doi.org\/10.1038\/s41598-024-82589-z"},{"key":"B49","series-title":"Acta Microbiol Immunol Hung","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1556\/030.2025.02730","article-title":"Prevalence of intestinal colonization by multidrug-resistant bacteria and related bloodstream infections in patients with hematological malignancies","volume":"72","author":"Stoeva T","year":"2025","unstructured":"Stoeva T, Niyazi D, Stoev L, Dokova K. Prevalence of intestinal colonization by multidrug-resistant bacteria and related bloodstream infections in patients with hematological malignancies. Acta Microbiol Immunol Hung 2025; 72: 341\u20139. 10.1556\/030.2025.02730https:\/\/doi.org\/10.1556\/030.2025.02730"},{"key":"B50","series-title":"Antibiotics","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/antibiotics13100920","article-title":"Prevalence and molecular epidemiology of intestinal colonization by multidrug-resistant bacteria among hematopoietic stem-cell transplantation recipients: a Bulgarian single-center study","volume":"13","author":"Niyazi D","year":"2024","unstructured":"Niyazi D, Vergiev S, Markovska R, Stoeva T. Prevalence and molecular epidemiology of intestinal colonization by multidrug-resistant bacteria among hematopoietic stem-cell transplantation recipients: a Bulgarian single-center study. Antibiotics 2024; 13: 920. 10.3390\/antibiotics13100920https:\/\/doi.org\/10.3390\/antibiotics13100920"},{"key":"B51","series-title":"Clin Transpl","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ctr.12356","article-title":"Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single\u2010center experience","volume":"28","author":"Shiratori S","year":"2014","unstructured":"Shiratori S, Wakasa K, Okada K, Sugita J, Akizawa K, Shigematsu A, et al. Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single\u2010center experience. Clin Transpl 2014; 28: 656\u201361. 10.1111\/ctr.12356https:\/\/doi.org\/10.1111\/ctr.12356"},{"key":"B52","series-title":"PLoS One","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201169.53","article-title":"Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival","volume":"13","author":"Scheich S","year":"2018","unstructured":"Scheich S, Koenig R, Wilke AC, Lindner S, Reinheimer C, Wichelhaus TA, et al. Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival. PLoS One 2018; 13: e0201169. 10.1371\/journal.pone.0201169.53https:\/\/doi.org\/10.1371\/journal.pone.0201169.53"},{"key":"B53","series-title":"Pharmaceuticals","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/ph16030466","article-title":"Cost-effectiveness of targeted prophylaxis among allogenic stem cell transplant recipients","volume":"16","author":"Shbaklo N","year":"2023","unstructured":"Shbaklo N, Vicentini C, Busca A, Giaccone L, Dellacasa C, Dogliotti I, et al. Cost-effectiveness of targeted prophylaxis among allogenic stem cell transplant recipients. Pharmaceuticals 2023; 16: 466. 10.3390\/ph16030466https:\/\/doi.org\/10.3390\/ph16030466"},{"key":"B54","series-title":"Mediterr J Hematol Infect Dis","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2023.022","article-title":"Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study","volume":"15","author":"Urbino I","year":"2023","unstructured":"Urbino I, Frairia C, Busca A, Corcione S, D'Ardia S, Dellacasa CM, et al. Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study. Mediterr J Hematol Infect Dis 2023; 15: e2023022. 10.4084\/MJHID.2023.022https:\/\/doi.org\/10.4084\/MJHID.2023.022"},{"key":"B55","series-title":"Mediterr J Infect Microbes Antimicrob","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4274\/mjima.galenos.2021.2021.52","article-title":"First investigation of OqxAB and plasmid mediated quinolone resistance determinants qnr genes in Stenotrophomonas maltophilia isolates","volume":"10","author":"Tanriverdi \u00c7ayci Y","year":"2021","unstructured":"Tanriverdi \u00c7ayci Y, Biyik I, Birinci A. First investigation of OqxAB and plasmid mediated quinolone resistance determinants qnr genes in Stenotrophomonas maltophilia isolates. Mediterr J Infect Microbes Antimicrob 2021; 10: 52. 10.4274\/mjima.galenos.2021.2021.52https:\/\/doi.org\/10.4274\/mjima.galenos.2021.2021.52"},{"key":"B56","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01436-20","article-title":"In vitro activity and in vivo efficacy of cefiderocol against Stenotrophomonas maltophilia","volume":"65","author":"Nakamura R","year":"2021","unstructured":"Nakamura R, Oota M, Matsumoto S, Sato T, Yamano Y. In vitro activity and in vivo efficacy of cefiderocol against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2021; 65: e01436-20. 10.1128\/AAC.01436-20https:\/\/doi.org\/10.1128\/AAC.01436-20"},{"key":"B57","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00559-20","article-title":"Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia","volume":"64","author":"Biagi M","year":"2020","unstructured":"Biagi M, Vialichka A, Jurkovic M, Wu T, Shajee A, Lee M, et al. Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2020; 64: e00559-20. 10.1128\/AAC.00559-20https:\/\/doi.org\/10.1128\/AAC.00559-20"},{"key":"B58","series-title":"Antibiotics","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/antibiotics12050910","article-title":"Stenotrophomonas maltophilia infections: a systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options","volume":"12","author":"Maraolo AE","year":"2023","unstructured":"Maraolo AE, Licciardi F, Gentile I, Saracino A, Belati A, Bavaro DF. Stenotrophomonas maltophilia infections: a systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options. Antibiotics 2023; 12: 910. 10.3390\/antibiotics12050910https:\/\/doi.org\/10.3390\/antibiotics12050910"},{"key":"B59","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-19","article-title":"In vitro activity of minocycline against U.S. isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: results from the SENTRY antimicrobial surveillance program, 2014 to 2018","volume":"63","author":"Flamm RK","year":"2019","unstructured":"Flamm RK, Shortridge D, Castanheira M, Sader HS, Pfaller MA. In vitro activity of minocycline against U.S. isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: results from the SENTRY antimicrobial surveillance program, 2014 to 2018. Antimicrob Agents Chemother 2019; 63: e01154-19. 10.1128\/AAC.01154-19https:\/\/doi.org\/10.1128\/AAC.01154-19"},{"key":"B60","series-title":"Int J Infect Dis","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107803","article-title":"Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018\u20132023)","volume":"153","author":"Sader HS","year":"2025","unstructured":"Sader HS, Mendes RE, Doyle TB, Winkler ML, Castanheira M. Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018\u20132023). Int J Infect Dis 2025; 153: 107803. 10.1016\/j.ijid.2025.107803https:\/\/doi.org\/10.1016\/j.ijid.2025.107803"},{"key":"B61","series-title":"J Microbiol Methods","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mimet.2018.12.002","article-title":"Multiplex real-time PCR assays to detect Stenotrophomonas maltophilia carrying sul1, sul2, and sul3 genes","volume":"156","author":"Li S","year":"2019","unstructured":"Li S, Peng Y, Rui Y. Multiplex real-time PCR assays to detect Stenotrophomonas maltophilia carrying sul1, sul2, and sul3 genes. J Microbiol Methods 2019; 156: 52\u20139. 10.1016\/j.mimet.2018.12.002https:\/\/doi.org\/10.1016\/j.mimet.2018.12.002"},{"key":"B62","series-title":"Emerg Infect Dis","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3201\/eid1304.061378","article-title":"Global emergence of trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes","volume":"13","author":"Toleman MA","year":"2007","unstructured":"Toleman MA, Bennett PM, Bennett DMC, Jones RN, Walsh TR. Global emergence of trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 2007; 13: 559\u201365. 10.3201\/eid1304.061378https:\/\/doi.org\/10.3201\/eid1304.061378"},{"key":"B63","series-title":"Int J Antimicrob Agents","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijantimicag.2010.10.025","article-title":"Stenotrophomonas maltophilia resistance to trimethoprim\/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron","volume":"37","author":"Hu LF","year":"2011","unstructured":"Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, et al. Stenotrophomonas maltophilia resistance to trimethoprim\/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents 2011; 37: 230\u20134. 10.1016\/j.ijantimicag.2010.10.025https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.10.025"},{"key":"B64","series-title":"Indian J Med Microbiol","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2024.100612","article-title":"Evaluation of the presence of integrons, sul and smqnr genes and the prevalence of antibiotic resistance in Stenotrophomonas maltophilia clinical isolates","volume":"49","author":"Mokhtari Bibalan M","year":"2024","unstructured":"Mokhtari Bibalan M, Mojtahedi A, Mahdieh N, Jafari A, Atrkar Roushan Z, Arya MJ. Evaluation of the presence of integrons, sul and smqnr genes and the prevalence of antibiotic resistance in Stenotrophomonas maltophilia clinical isolates. Indian J Med Microbiol 2024; 49: 100612. 10.1016\/j.ijmmb.2024.100612https:\/\/doi.org\/10.1016\/j.ijmmb.2024.100612"},{"key":"B65","series-title":"Infect Dis (Lond)","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/23744235.2020.1792545","article-title":"Characterization of an extensively drug-resistant Stenotrophomonas maltophilia clinical isolate with strong biofilm formation ability from Bulgaria","volume":"52","author":"Strateva T","year":"2020","unstructured":"Strateva T, Trifonova A, Savov E, Mitov I, Peykov S. Characterization of an extensively drug-resistant Stenotrophomonas maltophilia clinical isolate with strong biofilm formation ability from Bulgaria. Infect Dis (Lond) 2020; 52: 841\u20135. 10.1080\/23744235.2020.1792545https:\/\/doi.org\/10.1080\/23744235.2020.1792545"},{"key":"B66","series-title":"Microbiol Resour Announc","doi-asserted-by":"publisher","DOI":"10.1128\/mra.00091-23","article-title":"Whole-genome sequencing of 11 high-risk clone ST111 Pseudomonas aeruginosa isolates from French hospitals","volume":"12","author":"Anbo M","year":"2023","unstructured":"Anbo M, Chichkova MAT, Gen\u00e7ay YE, Salazar A, Jeannot K, Jelsbak L. Whole-genome sequencing of 11 high-risk clone ST111 Pseudomonas aeruginosa isolates from French hospitals. Microbiol Resour Announc 2023; 12: e00091-23. 10.1128\/mra.00091-23https:\/\/doi.org\/10.1128\/mra.00091-23"},{"key":"B67","series-title":"Front Microbiol","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.611246","article-title":"Within-host microevolution of Pseudomonas aeruginosa urinary isolates: a seven-patient longitudinal genomic and phenotypic study","volume":"11","author":"Cottalorda A","year":"2021","unstructured":"Cottalorda A, Leoz M, Dahyot S, Gravey F, Grand M, Froidure T, et al. Within-host microevolution of Pseudomonas aeruginosa urinary isolates: a seven-patient longitudinal genomic and phenotypic study. Front Microbiol 2021; 11: 611246. 10.3389\/fmicb.2020.611246https:\/\/doi.org\/10.3389\/fmicb.2020.611246"},{"key":"B68","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1128\/AAC.42.10.2557","article-title":"Characterization of In40 of Enterobacter aerogenes BM2688, a class 1 integron with two new gene cassettes, cmlA2 and qacF","volume":"42","author":"Ploy MC","year":"1998","unstructured":"Ploy MC, Courvalin P, Lambert T. Characterization of In40 of Enterobacter aerogenes BM2688, a class 1 integron with two new gene cassettes, cmlA2 and qacF. Antimicrob Agents Chemother 1998; 42: 2557\u201363. 10.1128\/AAC.42.10.2557https:\/\/doi.org\/10.1128\/AAC.42.10.2557"},{"key":"B69","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00724-21","article-title":"Exploring the global spread of Klebsiella grimontii isolates possessing blaVIM-1 and mcr-9","volume":"65","author":"Campos-Madueno EI","year":"2021","unstructured":"Campos-Madueno EI, Moser AI, Risch M, Bodmer T, Endimiani A. Exploring the global spread of Klebsiella grimontii isolates possessing blaVIM-1 and mcr-9. Antimicrob Agents Chemother 2021; 65: e00724-21. 10.1128\/AAC.00724-21https:\/\/doi.org\/10.1128\/AAC.00724-21"},{"key":"B70","series-title":"Emerg Infect Dis","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3201\/eid2406.171648","article-title":"Genomic epidemiology of global carbapenemase-producing Enterobacter spp., 2008\u20132014","volume":"24","author":"Peirano G","year":"2018","unstructured":"Peirano G, Matsumura Y, Adams MD, Bradford P, Motyl M, Chen L, et al. Genomic epidemiology of global carbapenemase-producing Enterobacter spp., 2008\u20132014. Emerg Infect Dis 2018; 24: 1010\u20139. 10.3201\/eid2406.171648https:\/\/doi.org\/10.3201\/eid2406.171648"}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/73\/1\/article-p59.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/73\/1\/article-p59.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/73\/1\/article-p59.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:13:03Z","timestamp":1772716383000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/73\/1\/article-p59.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":140,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1556\/030.2026.02794","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}